Individualized cancer vaccines and antibody-drug conjugates will be among the dominant biotech innovations in cancer next ...

Jim Lacamp, Morgan Stanley Wealth Management senior vice president, joins CNBC's 'Money Movers' to discuss his outlook on the ...

In recent years, there has been a noted increase in the rates of chronic disease, as well as a growth in the number of ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Morgan Stanley maintains a solid balance sheet, with assets reaching $1.26t and shareholder equity rising to $103.6b. Read ...

MS stock gains 32.4% this year. With the revival of global M&As, read on to know how 2025 will be for the stock and what ...

Read here for the advantages and risks of Morgan Stanley's Series A preferred shares vs. CoCos, with insights on market ...

Morgan Stanley’s stock (NYSE: MS) gained over 30% year-to-date. This compares to rival Goldman Sachs stock, which has seen its stock gain over 40% year-to-date. So what are some of the trends ...

Dominion Energy Inc (D) stock saw a modest uptick, ending the day at $53.77 which represents a slight increase of $0.09 or 0.17% from the prior close of $53.68. The stock opened at $53.32 and touched ...

Morgan Stanley has teamed up with cross-border money transmitter Wise to settle foreign-exchange payments for the investment ...

Nvidia’s (NASDAQ:NVDA) seemingly never-ending surge has been more muted in recent times. While sentiment has far from soured ...

Has Nvidia (NASDAQ:NVDA) stock peaked? That’s the big question as the centerpiece of the artificial intelligence movement has ...